Arachidonic acid metabolism

“Arachidonic acid derivatives formation” is not a specific molecule or receptor but refers to the enzymatic processes involved in the metabolism of arachidonic acid, a major polyunsaturated fatty acid present in cell membranes. Upon cellular activation, arachidonic acid is released (primarily by phospholipase A2) and metabolized through three principal pathways: the cyclooxygenase (COX) pathway yielding prostaglandins and thromboxanes, the lipoxygenase (LOX) pathway producing leukotrienes and lipoxins, and the cytochrome P450 (CYP450) pathway generating various HETEs and epoxides[1][2][4][7]. These derivatives, known as eicosanoids, play critical roles in inflammation, vascular tone, immunity, hemostasis, and other physiological processes, and their dysregulation is implicated in a range of diseases including cardiovascular conditions, cancers, and chronic inflammatory disorders[1][2][7]. Drug therapies commonly target specific enzymes within these metabolic pathways, but “arachidonic acid derivatives formation” as a whole is not a single druggable target; rather, it denotes a network of metabolic events and enzymes[1][5][7].

Other names

Arachidonic acid derivatives formationArachidonic acid pathwayArachidonic acid cascadeArachidonic acid metabolic pathways

Inhibition of cyclooxygenase (COX) enzymes, inhibition of lipoxygenase (LOX) enzymes, inhibition/modulation of cytochrome P450 (CYP450) epoxygenase/hydroxylase enzymes, reduction of pro-inflammatory eicosanoids